Morgan Stanley Tff Pharmaceuticals, Inc. Transaction History

Morgan Stanley

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.43 - $0.77 $86 - $154	-200 Reduced 9.92%	1,816 $0
Q1 2023 May 15, 2023	SELL	$0.62 - $1.1 $3,744 - $6,644	-6,040 Reduced 74.98%	2,016 $1,000
Q4 2022 Feb 14, 2023	BUY	$0.84 - $100.75 $5,067 - $607,824	6,033 Added 298.22%	8,056 $8,000
Q3 2022 Nov 14, 2022	SELL	$4.61 - $116.0 $22,773 - $573,040	-4,940 Reduced 70.95%	2,023 $8,000
Q2 2022 Oct 27, 2022	BUY	$3.99 - $7.22 $10,880 - $19,688	2,727 Added 64.38%	6,963 $39,000
Q2 2022 Aug 15, 2022	BUY	$3.99 - $7.22 $10,880 - $19,688	2,727 Added 64.38%	6,963 $39,000
Q1 2022 Oct 27, 2022	SELL	$5.28 - $9.17 $14,398 - $25,006	-2,727 Reduced 39.16%	4,236 $26,000
Q1 2022 May 13, 2022	SELL	$5.28 - $9.17 $2,344 - $4,071	-444 Reduced 9.49%	4,236 $26,000
Q4 2021 Feb 14, 2022	SELL	$6.86 - $9.65 $9,405 - $13,230	-1,371 Reduced 22.66%	4,680 $43,000
Q3 2021 Nov 15, 2021	BUY	$7.21 - $10.49 $43,627 - $63,474	6,051 New	6,051 $47,000

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $1.53M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.